MicroPort NeuroScientific Corporation (HKG:2172)

Market Cap	5.17B -42.2%
Revenue (ttm)	879.66M +3.8%
Net Income	205.32M -27.4%
EPS	0.36 -27.1%
Shares Out	574.09M
PE Ratio	25.27
Forward PE	18.53
Dividend	0.14 (1.54%)
Ex-Dividend Date	Jul 2, 2026

Volume	2,128,000
Open	9.08
Previous Close	9.12
Day's Range	8.97 - 9.28
52-Week Range	8.40 - 16.44
Beta	-0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About MicroPort NeuroScientific

MicroPort NeuroScientific Corporation provides neuro-interventional medical devices. The company provides NUMEN Silk, a electronically detachable coil; Numen Lighting, a coil embolization system; Numen Nest, a detachable coil; NuFairy absorbable coil embolization system; Tubridge, a flow-diverting stent; Tubridge Plus, a flow-diverting stent; WILLIS, a intracranial stent graft system; Comaneci, a embolization assist device; and Rebridge, an intracranial visualized stent for intracranial aneurysm, as well as liquid embolic agent for cerebral art...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 547
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2172

Financial Performance

In 2025, MicroPort NeuroScientific's revenue was 790.48 million, an increase of 3.77% compared to the previous year's 761.76 million. Earnings were 184.51 million, a decrease of -27.41%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error